Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy

Journal of Pediatrics

Volumn 137, Issue 3, 2000, Pages 386-392

  Chiarelli, Francesco ^a,b,c,d   Pomilio, Mariapina ^a,b,c,d   Mohn, Angelika ^a,b,c,d   Tumini, Stefano ^a,b,c,d   Vanelli, Maurizio ^a,b,c,d   Morgese, Guido ^a,b,c,d   Spagnoli, Anna ^a,b,c,d   Verrotti, Alberto ^a,b,c,d  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHIONINE;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0033823395     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.108103     Document Type: Article

References (43)

1. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whiteall study
2. Diabetes mellitus and macrovascular complications: An epidemiological perspective
3. Vascular thrombosis in diabetes
4. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus
5. Albuminuria reflects widespread vascular damage: The Steno hypothesis
6. Prospective study of microalbuminuria as predictor of mortality in NIDDM
7. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus
8. LDL subclasses in IDDM patients: Relation to diabetic nephropathy
9. Increased plasma apolipoprotein(a) levels in IDDM patients with diabetic nephropathy
10. Plasma total homocysteine, B vitamin, and risk of coronary atherosclerosis
11. Prospective study of serum total concentration of homocysteine and risk of stroke in middle-aged British men
12. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease
13. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease?
14. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM
15. Classification of diabetes mellitus and other categories of glucose intolerance
16. Diabetic retinopathy: Assessment of severity and progression
17. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction
18. Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinaemia
19. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study
20. Plasma homocysteine and cardiovascular disease
21. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
22. Homocysteine and atherothrombosis
23. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
24. Plasma homocyst(e)ine and hemostasis: The ARIC Study
25. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells
26. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
27. Can lowering homocysteine levels reduce cardiovascular risk?
28. Features of endothelial dysfunction in early diabetic nephropathy
29. Changes in blood coagulation, platelet function and plasminogen-plasmin system in diabetes
30. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM
31. Insulin as a mitogenic factor: Role in the pathogenesis of cardiovascular disease
32. Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus
33. Plasma homocysteine concentrations in patients with type 1 diabetes
34. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study
35. Moderate hyper-homocysteinaemia and retinopathy in insulin dependent diabetes
36. Plasma homocysteine and all-cause mortality in diabetes
37. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study
38. Homocysteine and other sulfhydryl compound enhance the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism
39. Inherited disorders of folate transport and metabolism
40. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham study
41. Determinants and vitamin responsiveness of intermediate hyperhomocysteinaemia (> or = 40 μmol/liter)
42. Genetic and non-genetic factors for moderate hyperhomocyst(e)inemia
43. Treatment of mild hyperhomocysteinaemia